Profile for questalinrascompra
|
SignatureBicalutamide, sold under the brand name Casodex among others, is an antiandrogen approval of bicalutamide for use specifically in the treatment of LPC was withdrawn in a number of countries including hormone-refractory prostate cancer: the Therapy Assessed by Rising PSA (TARP) study rationale and...
|
